Inhibition of MEK1 signaling pathway in the liver ameliorates insulin resistance

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,311 · see citing works

22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features

Burnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,958 · see citing works

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle

Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · see citing works

The Primary Structure of MEK, a Protein Kinase that Phosphorylates the ERK Gene Product

Crews, C. M., Alessandrini, A., & Erikson, R. L. (1992) · Science · doi:10.1126/science.1411546 · Cited by 930 · see citing works

Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout Mice

Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., & Pouysségur, J. (1999) · Science · doi:10.1126/science.286.5443.1374 · Cited by 654 · see citing works

Identification of the sites in MAP kinase kinase‐1 phosphorylated by p74raf‐1.

Alessi, D. R., Saito, Y., Campbell, D. G., Cohen, P., Sithanandam, G., Rapp, U. R., Ashworth, A., Marshall, C. J., & Cowley, S. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06424.x · Cited by 562 · see citing works

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.

Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · see citing works

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

Tilg, H., & Moschen, A. R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.005 · Cited by 470 · see citing works

Knockout of ERK1 MAP Kinase Enhances Synaptic Plasticity in the Striatum and Facilitates Striatal-Mediated Learning and Memory

Mazzucchelli, C., Vantaggiato, C., Ciamei, A., Fasano, S., Pakhotin, P., Krezel, W., Welzl, H., Wolfer, D. P., Pagès, G., Valverde, O., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00716-x · Cited by 456 · see citing works

Signalling by insulin and IGF receptors: supporting acts and new players

Siddle, K. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0022 · Cited by 456 · see citing works

The clinical development of MEK inhibitors

Zhao, Y., & Adjei, A. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.83 · Cited by 403 · see citing works

Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients

Krook, A., Björnholm, M., Galuska, D., Jiang, X. J., Fahlman, R., Myers, M. G., Wallberg-Henriksson, H., & Zierath, J. R. (2000) · Diabetes · doi:10.2337/diabetes.49.2.284 · Cited by 375 · see citing works

An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development

Saba‐El‐Leil, M. K., Vella, F. D. J., Vernay, B., Voisin, L., Chen, L., Labrecque, N., Ang, S., & Meloche, S. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor939 · Cited by 366 · see citing works

Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta

Giroux, S., Tremblay, M. G., Bernard, D., Cardin-Girard, J.-F., Aubry, S., Larouche, L., Rousseau, S., Huot, J. L., Landry, J., Jeannotte, L., et al. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80164-x · Cited by 342 · see citing works

The Extracellular Signal–Regulated Kinase Isoform ERK1 Is Specifically Required for In Vitro and In Vivo Adipogenesis

Bost, F., Aouadi, M., Caron, L., Even, P. C., Belmonte, N., Prot, M., Dani, C., Hofman, P. M., Pagès, G., Pouysségur, J., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.2.402 · Cited by 337 · see citing works

Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation

Yao, Y., Li, W., Wu, J., Germann, U. A., Su, M. S. S., Kuida, K., & Boucher, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134254100 · Cited by 323 · see citing works

Essential role for ERK2 mitogen‐activated protein kinase in placental development

Hatano, N., Mori, Y., Oh‐hora, M., Kosugi, A., Fujikawa, T., Nakai, N., Niwa, H., Miyazaki, J., Hamaoka, T., & Ogata, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00680.x · Cited by 296 · see citing works

Effect of 5-Aminoimidazole-4-Carboxamide-1-β- d -Ribofuranoside Infusion on In Vivo Glucose and Lipid Metabolism in Lean and Obese Zucker Rats

Bergeron, R., Previs, S. F., Cline, G. W., Perret, P., Russell, R. R., Young, L. H., & Shulman, G. I. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1076 · Cited by 280 · see citing works

Regulation of Pancreatic β Cell Mass by Neuronal Signals from the Liver

Imai, J., Katagiri, H., Yamada, T., Ishigaki, Y., Suzuki, T., Kudo, H., Uno, K., Hasegawa, Y., Gao, J., Kaneko, K., et al. (2008) · Science · doi:10.1126/science.1163971 · Cited by 236 · see citing works

Mice Lacking the ERK1 Isoform of MAP Kinase Are Unimpaired in Emotional LearningPreprint

Selcher, J. C., Nekrasova, T., Paylor, R. E., Landreth, G. E., & Sweatt, J. D. (2001) · Learning & Memory · doi:10.1101/lm.37001 · Cited by 211 · see citing works

Three Mitogen-Activated Protein Kinases Inhibit Insulin Signaling by Different Mechanisms in 3T3-L1 Adipocytes

Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Abe, M., Shojima, N., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0131 · Cited by 184 · see citing works

Enhanced Inhibition of ERK Signaling by a Novel Allosteric MEK Inhibitor, CH5126766, That Suppresses Feedback Reactivation of RAF Activity

Ishii, N., Harada, N., Joseph, E. W., Ohara, K., Miura, T., Sakamoto, H., Matsuda, Y., Tomii, Y., Tachibana-Kondo, Y., Iikura, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3937 · Cited by 179 · see citing works

Discovery of Tofogliflozin, a Novel C-Arylglucoside with an O-Spiroketal Ring System, as a Highly Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Ohtake, Y., Sato, T., Kobayashi, T., Nishimoto, M., Taka, N., Takano, K., Yamamoto, K., Ohmori, M., Yamaguchi, M., Takami, K., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300884k · Cited by 174 · see citing works

Studies on a diabetic (KK) strain of the mouse

Nakamura, M., & Yamada, K. (1967) · Diabetologia · doi:10.1007/bf01222198 · Cited by 172 · see citing works

First-in-Human, Phase I Dose-Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of RO5126766, a First-in-Class Dual MEK/RAF Inhibitor in Patients with Solid Tumors

Martinez‐García, M., Banerji, U., Albanell, J., Bahleda, R., Dolly, S. O., Kraeber‐Bodéré, F., Rojo, F., Routier, É., Guarin, E., Xu, Z., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0742 · Cited by 153 · see citing works

Hepatocyte Nuclear Factor-1α Recruits the Transcriptional Co-Activator p300 on the GLUT2 Gene Promoter

Ban, N., Yamada, Y., Someya, Y., Miyawaki, K., Ihara, Y., Hosokawa, M., Toyokuni, S., Tsuda, K., & Seino, Y. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1409 · Cited by 95 · see citing works

Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent

Isshiki, Y., Kohchi, Y., Iikura, H., Matsubara, Y., Asoh, K., Murata, T., Kohchi, M., Mizuguchi, E., Tsujii, S., Hattori, K., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.01.062 · Cited by 80 · see citing works

Activating transcription factor-2 is a positive regulator in CaM kinase IV-induced human insulin gene expression.

Ban, N., Yamada, Y., Someya, Y., Ihara, Y., Adachi, T., Kubota, A., Watanabe, R., Kuroe, A., Inada, A., Miyawaki, K., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1142 · Cited by 78 · see citing works

Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with <i>RAS–RAF</i> Mutations

Zimmer, L., Barlesi, F., Martinez-Garcia, M., Dieras, V., Schellens, J. H. M., Spano, J.-P., Middleton, M. R., Calvo, E., Paz-Ares, L., Larkin, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0341 · Cited by 71 · see citing works

ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells

Izawa, Y., Yoshizumi, M., Fujita, Y., Ali, N., Kanematsu, Y., Ishizawa, K., Tsuchiya, K., Obata, T., Ebina, Y., Tomita, S., et al. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.028 · Cited by 69 · see citing works

Sensitive LC MS quantitative analysis of carbohydrates by Cs+ attachment

Rogatsky, E., Jayatillake, H., Goswami, G., Tomuta, V., & Stein, D. T. (2005) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2005.07.017 · Cited by 66 · see citing works

Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats

Nagata, T., Fukazawa, M., Honda, K., Yata, T., Kawai, M., Yamane, M., Murao, N., Yamaguchi, K., Kato, M., Mitsui, T., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00545.2012 · Cited by 45 · see citing works

Regulation of MAP kinase pathway activity in vivo in human skeletal muscle

Osman, A. A., Pendergrass, M., Koval, J., Maezono, K., Cusi, K. J., Pratipanawatr, T., & Mandarino, L. J. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.6.e992 · Cited by 42 · see citing works

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of CH4987655 in Healthy Volunteers: Target Suppression Using a Biomarker

Lee, L., Niu, H., Rueger, R., Igawa, Y., Deutsch, J., Ishii, N., Mu, S., Sakamoto, Y., Busse‐Reid, R., Gimmi, C. D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1696 · Cited by 41 · see citing works

Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors

Honda, K., Yamamoto, N., Nokihara, H., Tamura, Y., Asahina, H., Yamada, Y., Suzuki, S., Yamazaki, N., Ogita, Y., & Tamura, T. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2228-4 · Cited by 29 · see citing works

The sulfamide moiety affords higher inhibitory activity and oral bioavailability to a series of coumarin dual selective RAF/MEK inhibitors

Aoki, T., Hyohdoh, I., Furuichi, N., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.001 · Cited by 20 · see citing works

Development and testing of a simple algorithm for a glucose clamp

Furler, S. M., Zelenka, G. S., & Kraegen, E. W. (1986) · Medical & Biological Engineering & Computing · doi:10.1007/bf02442689 · Cited by 19 · see citing works

Managing The Skin Toxicities From New Melanoma Drugs

Mavropoulos, J. C., & Wang, T. S. (2014) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0284-6 · Cited by 18 · see citing works

Effects of Nutritional Factors on the Development of Ethanol-induced Fatty Liver in KK and KK-Ay Mice

Furuno, K., Shimakawa, K., & Suzuoki, Z. (1975) · Journal of Nutrition · doi:10.1093/jn/105.10.1263 · Cited by 9 · see citing works

Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases

Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272 · see citing works

Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice

Lombardo, G. E., Lepore, S. M., Morittu, V. M., Arcidiacono, B., Colica, C., Procopio, A., Maggisano, V., Bulotta, S., Costa, N., Mignogna, C., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00116 · Cited by 55 · see citing works

Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRβ/IRS-1 and Akt

Zhou, J., & Huang, K. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.005 · Cited by 27 · see citing works

Saturated fatty acids-induced miR-424–5p aggravates insulin resistance via targeting insulin receptor in hepatocytes

Min, K.-H., Yang, W., & Lee, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.084 · Cited by 45 · see citing works

Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells

YIP-SCHNEIDER, M. T., Klein, P. J., Wentz, S. C., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147306 · Cited by 34 · see citing works

Abstract 2150: Alternative treatment strategies to overcome MAPK inhibitor resistance in melanoma

Goetz, E. M., Rabasha, B., & Garraway, L. A. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-2150

Molecular mechanisms of insulin resistance in chronic kidney disease

Thomas, S. S., Zhang, L., & Mitch, W. E. (2015) · Kidney International · doi:10.1038/ki.2015.305 · Cited by 113 · see citing works